REQUEST A DEMO
Total
USD $0.00
Search more companies

Dna Laboratories Sdn. Bhd. (Malaysia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Specialty (except Psychiatric and Substance Abuse) Hospitals
Full name: Dna Laboratories Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Research, development and manufacturing of in-vitro dna based molecular dignostic kits and provides laboratory services for genetic screening to detect human chromosomal abnormalities; licensing of in-vitro dna.

Headquarters
No.B1-3 & B1-4, Block Plasma, Ukm-Mtdc Technology Centre
Hulu Langat; Selangor; Postal Code: 43600

Contact Details: Purchase the Dna Laboratories Sdn. Bhd. report to view the information.

Website: http://www.dna-laboratories.com

Basic Information
Outstanding Shares:
Purchase the Dna Laboratories Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Dna Laboratories Sdn. Bhd. report to view the information.
Incorporation Date:
June 07, 2006
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Sml Dna Company Limited
51%
Company Performance
Financial values in the chart are available after Dna Laboratories Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-39.24%
Total operating revenue
-39.24%
Operating profit (EBIT)
-89.29%
EBITDA
-79.42%
Net Profit (Loss) for the Period
-93.23%
Total assets
-9.5%
Total equity
4.51%
Operating Profit Margin (ROS)
-33.52%
Net Profit Margin
-27.54%
Return on Equity (ROE)
-58.83%
Debt to Equity Ratio
0.25%
Quick Ratio
3.74%
Cash Ratio
2.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?